Can therapy help pregnant women stay on HIV prevention? new study aims to find out.

NCT ID NCT05624931

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a short counseling program (about 4 sessions) designed to help pregnant and postpartum women in Cape Town, South Africa, keep taking their daily HIV-prevention pill (PrEP). Many women stop PrEP due to depression or trauma from violence. The program uses cognitive behavioral therapy (CBT) to improve coping and build healthy habits. Researchers will enroll 118 women to see if the program is feasible and acceptable, and whether it helps them stay on PrEP during pregnancy and after birth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Brief CBT-based behavioral intervention

What this could lead to

If it works, this could point toward a practical, low-cost way to help pregnant women at high HIV risk stay on PrEP by treating underlying depression and trauma.

What could go wrong

This is a small, early-stage pilot study (118 participants) testing feasibility and acceptability, not effectiveness. The intervention is still being developed, so results may not generalize or show clear benefit.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression depressive disorder Medication Adherence post-traumatic stress disorder pregnancy disorder HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Boston University

    NOT_YET_RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Gugulethu Midwife Obstetric Unit (MOU)

    RECRUITING

    Cape Town, Western Cape, 8001, South Africa

    Contact Phone: •••-•••-•••• Email: •••••@•••••